Practical Protocols – experience and evidence based routines Henrik Ekberg.

Slides:

Advertisements

Similar presentations

Kidney Dialysis and Transplants

Advertisements

Renal Process Mapping from Renal Stakeholder Event Emergency Diagnostic tests ordered Secondary Referral General Practitioner General Practitioner Tertiary.

THE FIRST THREE MONTHS.  UTI in 40 to 70% of transplant patients within first 3 months  Increased risk of Klebsiella, enterococcus, pseudomonas  Gram.

+ Case Study One Pediatric Patient’s Experience Shelley Chapman RN, BSN, CCTC Children’s Hospital of Wisconsin.

CN-1 Everolimus Renal Safety and Efficacy Extrapolations, Dose Recommendations Lawrence Hunsicker, MD Professor of Medicine and Medical Director of Organ.

30-Year Retrospective on Organ Transplant Immunosuppression in the Era of Calcineurin Inhibitors Herwig-Ulf Meier-Kriesche, MD Professor of Medicine Department.

ISKDC. Primary nephrotic syndrome in children: Clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity.

Effect of Obesity on Kidney Transplantation Reference: Potluri K, Hou S. Obesity in kidney transplant recipients and candidates. Am J Kidney Dis. 2010;56:143–156.

SYMPHONY: Results at 12 Months. Daclizumab Low dose CsA MMF Steroids B 50–100 ng/ml Low dose SRL D MMF Steroids Daclizumab 4-8 ng/ml Low dose TAC MMF.

Recent management of Renal Transplantation in a Developing Country like Bangladesh, R Alam, Islam M S, R Alam, H Rahman, HU Rashid Department of Nephrology,

Organ Donation & Transplantation in Ireland – Changing times Aileen Counihan Transplant Co-ordinator Beaumont Hospital Beaumont Hospital.

Regional Transplant Forum Sept Current national format NHSBT Kidney Advisory Group Renal Transplant Clinical Reference Group NHS England BTS Guidelines.

The Recipient Experience Jaime Myers, RN, MSN, CCTC April 29, 2011.

Ordering Heart Transplantation Miria Grisot Dept. of Informatics University of Oslo.

MEDICAL ASPECTS OF LIVING KIDNEY DONATION Introduction:  Kidney Tx cannot Proceed without donor.  Appropriate identification & preparation of the donors.

Renal Transplant Patient Education

Heart Transplants. Statistics 1000’s die every year waiting for a heart transplant 100,000’s of people diagnosed with heart failure every year Heart Failure.

An Anaesthetist’s perspective on Same Day Surgery

Comprehensive Transplant Center One Day Evaluation Work-Flow Lisa M. Rhodes Sr. Administrative Associate.

Clinical Management of the HIV Infected Transplant Recipient: How to Balance the Needs of the Patient and the Health Care Team.

Clinical Unit of Health Promotion WHO Collaborating Centre for Evidence-Based Health Promotion in Hospitals Quality tools and Health Promotion Implementation.

Living Donor Kidney Transplant April 15, 2012 Margaret Leid Transplant Community Liaison Penn Transplant Institute

Perioperative Testing

Development of Clinical Practice Guidelines for the NHS Dr Jacqueline Dutchak, Director National Collaborating Centre for Acute Care 16 January 2004.

Management of Adults with Diabetes undergoing Surgery and Elective Procedures UHL Guideline – April 2013 The aim of the guideline is to improve standards.

Strategies for Maximizing Outcomes in Liver Transplantation James D. Eason, M.D. Chief of Transplantation / Professor of Surgery University of Tennessee.

Tolerance Induction after Kidney Transplantation Stephan Busque MD M Sc FRCSC Director, Adult Kidney and Pancreas Transplantation Program Stanford University.

Overview of operational research in MSF Myriam Henkens, MD, MPH International Medical Coordinator MSF London 1st of June, 2006.

Clinical Management of Kidney Transplants Dr. Michael Hadjigavriel Director Nephrology Larnaca General Hospital Cyprus Overview-

Introduction to Pharmacotherapy Ghada A Bawazeer. MSc, PharmD. BCPS King Saud University-College of Pharmacy Sept

TRANSMISSION OF TUBERCULOSIS BY KIDNEY DONATION Vanessa dos Santos Silva, Isis de Figueiredo Alfredo Guimarães, Ana Paula Maia Baptista, Marina Pontello.

Scottish Patient Safety Programme – Pharmacist Engagement Gordon Thomson Arlene Coulson Shadi Botros.

Experience with Calcineurin Inhibitor-Free Immunosuppression in Kidney Transplantation with Marginal Donors Oppenheimer F, Saval N, Gutierrez A, Cam pistol.

Study of cytokine gene polymorphism and graft outcome in live-donor kidney transplantation By Rashad Hassan MD Amgad El-Agroudy, Ahmad Hamdy, Amani Mostafa.

Severe vascular lesions and poor functional outcome

CMV (Cytomegalovirus) reactivation and immunosupression in allogeneic transplantation Marie Waller Bone Marrow Transplant Coordinator Manchester Royal.

Acute Oncology Dr Nicola Storey.

CR-1 Everolimus Benefit/Risk Assessment Howard J. Eisen, MD Thomas J. Vischer Professor of Medicine Chief, Division of Cardiology Drexel University College.

Fabry disease in donor kidneys with 3 and 12 years follow-up after transplantation Willy Aasebø 1, Erik H. Strøm 2, Torstein Hovig 2, Liv H. Undset 1 Arvid.

Minority Affairs Committee Fall  Patient resource promoting early referral for transplant evaluation  Collaborated with Patient Affairs Committee.

Open-label W24 ≥ 18 years Chronic HCV infection All genotypes HCV RNA ≥ 10,000 IU/ml Liver transplantation months earlier Child Pugh ≤ 7 and MELD.

RAD Immunosuppression in Heart Transplant Recipients Duke Heart Failure Research Pager:

Pharmacokinetic Questions

Thymoglobulin: An Overview of Its Performance in Clinical Trials as an Agent for the Induction Therapy Reference: Osama Gaber A, Knight RJ, Patel S, et.

Case 2 A 23-year old Indian young man Homozygous Beta-Thalassemia Major Diagnosed at the age of 6 months. On regular transfusion every 4 weeks since that.

UHNS Pre transplant Information Welcome from us Jo Claughton Caroline Clark Gail Leigh Kay Dimmick Barbara Hartley Dominic de Takats Kerry Tomlinson.

History of Kidney Transplantation

Preemptive Kidney Transplant (PKT) – the Optimal Therapy in ESRD Reference: Connie L. Davis. Preemptive transplantation and the transplant first initiative.

Hepatitis B virus infection in renal transplant recipients

1 Infectious Disease Verification to Enhance Patient Safety Operations and Safety Committee.

11/11/16 Kirstie Wallace/Hazel Muse Transplant Co-ordinators

EXPERIENCE WITH ALEMTUZUMAB IN KIDNEY TRASPLANTATION

CASE PRESENTATION DR SANJAY MAITRA, DR DENISH SAVALIA,

Expanding the Donation Opportunity:

KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients 순천향대학교 서울병원 신장내과 R2 김윤석.

Renal Transplant Patient Education

Maintaining Your Kidney Transplant: The Winning Game Plan

The Organ Donation Process

considering further dose(s)

Exam Room Health Center Health Center Front Desk Waiting Room

The Organ Donation Process

Critical Care Capacity & Immediate Life Preserving Treatment

An Observational Study on Thrombotic Microangiopathy in Renal Transplant Recipients - A Tertiary Care Centre Experience. Dr Sarang Vijayan Senior Resident.

Operations and Safety Committee

Best Heart Surgeon In India Million of surgeries are done each year to correct heart problems among children and adults. Although there are more than a.

Intrapatient variability in cyclosporine blood levels in renal transplant patients. Intrapatient variability in cyclosporine blood levels in renal transplant.

Current standard of care treatment protocols for LN induction therapy.

25 May 2019 Emerging issues: The new Council of Europe Guide for the Quality and Safety of Organs for Transplantation 7th International Congress Infection.

Presentation transcript:

Practical Protocols – experience and evidence based routines Henrik Ekberg

Living Donor Kidney Transplantation - Protocols Why do we need protocols? Every transplant centre needs to make decisions on their routine practice. The reason for this is that all patients should be given the best possible care. These protocols should be based on current transplantation research They should be updated at regular intervals. The objective is to reach the highest international standard of outcome after kidney transplantation.

How to make your own protocols The book is published in Chinese and in English. With the book you should find a CD. If you want to make a print out of the same text as in the book, use the pdf file. If you want to make your own protocols, similar to what we have suggested but with an update or with local application, use the Word file.

A message from The Transplantation Society Professor Jeremy Chapman, President, TTS “This book provides the practical elements needed for a modern transplantation programme. It is absolutely essential in today’s clinical transplant programmes that all the professional staff work as a unit. Without protocols covering the most important aspects of transplant care there is no cohesion or collaboration. These Practical Protocols provide all transplant units the opportunity to build their own protocols easily and on a sound basis of international best practice. “

Structure of the Transplant Centre Director Transplant Centre Transplant Surgery Vice Director Transplant Nephrology Vice Director Transplant Laboratories Risk assessment Cardiology Transplant Co-ordinator

Protocols 1. Kidney Recipient Work Up 2. Living Donor Work Up 3. Consent to Kidney Donation 4. Protocols for the Doctor: Admission of the Recipient Before Transplantation 5. Protocols for the Nurse: Admission of the Recipient Before Transplantation 6. Doctor’s Orders: Pre-operative Management in Kidney Transplantation

(1) Kidney Recipient work up 1.Cardiac evaluation 2.Parathyroid function 3.Glucose tolerance 4.APC resistance 5.Panel reactive antibodies 6.Dentist 7.Antibody screening (HIV, HBV, HCV, etc) 8.Vaccination 9.CT of iliac arteries

(2) Living Donor Work Up 1.Informed consent 2.Blood group test 3.Electrocardiogram 4.Clinical chemistry according to a specified list 5.GFR 6.Glucose tolerance test 7.Echocardiogram 8.Renal artery ultrasound 9.Chest X-ray 10.Myocardial scintigraphy (if > 50 yrs old) 11.CT angiography of renal arteries 12.Nephrologist’s decision 13.Surgeon’s decision

More Protocols 7. Anaesthetist: Intra-operative Management in Kidney Transplantation 8. Post-operative Management After Kidney Transplantation 9. Routine Blood Samples After Kidney Transplantation For the Nurse in the Transplant Ward 10. Flow Chart of Events of Nursing After Kidney Transplantation 11. Flow Chart of Events of Nursing in Kidney Donation 12. Long-term Follow-up After Kidney Donation 13. Antibiotics and Kidney Transplantation

(14) Initial Immunosuppression After Kidney Transplantation 1. Normal risk patient (with basiliximab) 2. Normal risk patient (with no induction) 3. NODAT risk (steroid avoidance) 4. NODAT risk (low-dose steroids) 5. High risk (with basiliximab induction) 6. High risk (with ATG induction)

(14) Initial Immunosuppression After Kidney Transplantation Normal risk (1) Normal risk (2) NODAT (1)NODAT (2)High risk (1) High risk (2) InductionBasiliximabNoneBasiliximab ATG Tac trough – – Start dose Mg/kg BID Start dose Mg BID for 70kg BW MMF g BID Prednisone Mg/day for 1 week then

(14) Initial Immunosuppression After Kidney Transplantation Normal risk (1) Normal risk (2) NODAT (1)NODAT (2)High risk (1) High risk (2) InductionBasiliximabNoneBasiliximab ATG Tac trough – – Start dose Mg/kg BID Start dose Mg BID for 70kg BW MMF g BID Prednisone Mg/day for 1 week then

(14) Initial Immunosuppression After Kidney Transplantation Normal risk (1) Normal risk (2) NODAT (1)NODAT (2)High risk (1) High risk (2) InductionBasiliximabNoneBasiliximab ATG Tac trough – – Start dose Mg/kg BID Start dose Mg BID for 70kg BW MMF g BID Prednisone Mg/day for 1 week then

(14) Initial Immunosuppression After Kidney Transplantation Normal risk (1) Normal risk (2) NODAT (1)NODAT (2)High risk (1) High risk (2) InductionBasiliximabNoneBasiliximab ATG Tac trough – – Start dose Mg/kg BID Start dose Mg BID for 70kg BW MMF g BID Prednisone Mg/day for 1 week then

(14) Initial Immunosuppression After Kidney Transplantation Normal risk (1) Normal risk (2) NODAT (1)NODAT (2)High risk (1) High risk (2) InductionBasiliximabNoneBasiliximab ATG Tac trough – – Start dose Mg/kg BID Start dose Mg BID for 70kg BW MMF g BID Prednisone Mg/day for 1 week then

(14) Initial Immunosuppression After Kidney Transplantation Normal risk (1) Normal risk (2) NODAT (1)NODAT (2)High risk (1) High risk (2) InductionBasiliximabNoneBasiliximab ATG Tac trough – – Start dose Mg/kg BID Start dose Mg BID for 70kg BW MMF g BID Prednisone Mg/day for 1 week then

(14) Initial Immunosuppression After Kidney Transplantation Normal risk (1) Normal risk (2) NODAT (1)NODAT (2)High risk (1) High risk (2) InductionBasiliximabNoneBasiliximab ATG Tac trough – – Start dose Mg/kg BID Start dose Mg BID for 70kg BW MMF g BID Prednisone Mg/day for 1 week then

Evening (8 pm) the day before transplantation Tacrolimus 0.05 mg/kg (e.g. 3.5 mg) MMF 1000 mg Morning of the day of transplantation (6 am) Tacrolimus 0.05 mg/kg MMF 1000 mg At the start of transplantation in the operating room Methylprednisolone 500mg IV Basiliximab 20 mg IV In the evening (8 pm) of the day of transplantation Tacrolimus 0.05 mg/kg MMF 1000 mg Prednisolone 100 mg IV Every day after transplantation (8 am and 8 pm) Days 1 – 30 Tacrolimus 0.05 mg/kg x 2 (target concentration 5 – 8 ng/mL) MMF 1000 mg x 2 Prednisone 15 mg at 8 am and 5 mg at 8 pm Day 4: basiliximab 20 mg IV Days 30-60Tacrolimus (target concentration ng/mL) MMF 750 mg x 2 Prednisolone 15 mg at 8 am Days 60-90Tacrolimus (target concentration 5 – 8 ng/mL) MMF 750 mg x 2 Prednisolone 10 mg at 8 am Days 90 and afterTacrolimus (target concentration 5 – 8 ng/mL) MMF 750 mg x 2 (or azathioprine 75 – 100 mg x 1) Prednisolone 5 mg at 8 am

Final Protocols 15. Transplant Biopsy 16. Treatment of Acute Rejection 17. Long-term Follow-up After Kidney Transplant 18. Responsibilities of Surgeon and Nephrologist 19. The Gift of a Kidney – Information for the Potential Donor 20. Further Reading

At your transplant center: Which protocols would you accept today as they are? Which protocols would you like to modify to make them applicable to your routines? Are there any protocols you would not use? Please, give me your comments and suggestions: